| 000 | 01368 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250513025834.0 | ||
| 264 | 0 | _c19951124 | |
| 008 | 199511s 0 0 eng d | ||
| 022 | _a0093-7754 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRoss, D D | |
| 245 | 0 | 0 |
_aConsequences of 2',2'-difluorodeoxycytidine (gemcitabine) on replicative DNA synthesis in intact HL-60 cells. _h[electronic resource] |
| 260 |
_bSeminars in oncology _cAug 1995 |
||
| 300 |
_a26-34 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aAntimetabolites, Antineoplastic _xpharmacology |
| 650 | 0 | 4 |
_aCytarabine _xpharmacology |
| 650 | 0 | 4 |
_aCytidine Triphosphate _xmetabolism |
| 650 | 0 | 4 |
_aDNA Replication _xdrug effects |
| 650 | 0 | 4 |
_aDNA, Neoplasm _xdrug effects |
| 650 | 0 | 4 |
_aDeoxycytidine _xanalogs & derivatives |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aGuanosine Triphosphate _xmetabolism |
| 650 | 0 | 4 |
_aHL-60 Cells _xdrug effects |
| 650 | 0 | 4 | _aHalf-Life |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNucleosides _xmetabolism |
| 650 | 0 | 4 |
_aPeptide Chain Elongation, Translational _xdrug effects |
| 650 | 0 | 4 |
_aThymine _xmetabolism |
| 650 | 0 | 4 | _aGemcitabine |
| 700 | 1 | _aCuddy, D P | |
| 773 | 0 |
_tSeminars in oncology _gvol. 22 _gno. 4 Suppl 11 _gp. 26-34 |
|
| 999 |
_c7481311 _d7481311 |
||